Eyfjörd JE - Search Results

1

TP53 mutations and breast cancer prognosis: particularly poor survival rates for cases with mutations in the zinc-binding domains.

Børresen AL, Andersen TI, Eyfjörd JE, Cornelis RS, Thorlacius S, Borg A, Johansson U, Theillet C, Scherneck S, Hartman S, et al. Børresen AL, et al. Among authors: eyfjord je. Genes Chromosomes Cancer. 1995 Sep;14(1):71-5. doi: 10.1002/gcc.2870140113. Genes Chromosomes Cancer. 1995. PMID: 8527388

2

Screening for germ line TP53 mutations in breast cancer patients.

Børresen AL, Andersen TI, Garber J, Barbier-Piraux N, Thorlacius S, Eyfjörd J, Ottestad L, Smith-Sørensen B, Hovig E, Malkin D, et al. Børresen AL, et al. Cancer Res. 1992 Jun 1;52(11):3234-6. Cancer Res. 1992. PMID: 1591732

3

Loss of heterozygosity at 7q31 in breast cancer: results from an International Collaborative Study Group. The Breast Cancer Somatic Genetics Consortium.

Devilee P, Hermans J, Eyfjörd J, Bøorresen AL, Lidereau R, Sobol H, Borg A, Cleton-Jansen AM, Oláh E, Cohen BB, Scherneck S, Hamann U, Peterlin B, Caligo M, Bignon YJ, Maugard C. Devilee P, et al. Genes Chromosomes Cancer. 1997 Mar;18(3):193-9. Genes Chromosomes Cancer. 1997. PMID: 9071572

4

Somatic p53 mutations in human breast carcinomas in an Icelandic population: a prognostic factor.

Thorlacius S, Börresen AL, Eyfjörd JE. Thorlacius S, et al. Among authors: eyfjord je. Cancer Res. 1993 Apr 1;53(7):1637-41. Cancer Res. 1993. PMID: 8453635

5

TP53 mutations and abnormal p53 protein staining in breast carcinomas related to prognosis.

Thorlacius S, Thorgilsson B, Björnsson J, Tryggvadottir L, Börresen AL, Ogmundsdottir HM, Eyfjörd JE. Thorlacius S, et al. Among authors: eyfjord je. Eur J Cancer. 1995 Oct;31A(11):1856-61. doi: 10.1016/0959-8049(95)00399-4. Eur J Cancer. 1995. PMID: 8541113

6

Consortium study on 1280 breast carcinomas: allelic loss on chromosome 17 targets subregions associated with family history and clinical parameters.

Phelan CM, Borg A, Cuny M, Crichton DN, Baldersson T, Andersen TI, Caligo MA, Lidereau R, Lindblom A, Seitz S, Kelsell D, Hamann U, Rio P, Thorlacius S, Papp J, Olah E, Ponder B, Bignon YJ, Scherneck S, Barkardottir R, Borresen-Dale AL, Eyfjörd J, Theillet C, Thompson AM, Larsson C, et al. Phelan CM, et al. Cancer Res. 1998 Mar 1;58(5):1004-12. Cancer Res. 1998. PMID: 9500463

7

Genetic changes in breast carcinomas in an Icelandic population.

Eyfjörd JE, Thorlacius S. Eyfjörd JE, et al. Pharmacogenetics. 1992 Dec;2(6):309-16. doi: 10.1097/00008571-199212000-00010. Pharmacogenetics. 1992. PMID: 1306132

8

TP53 abnormalities and genetic instability in breast cancer.

Eyfjörd JE, Thorlacius S, Valgardsdottir R, Gretarsdottir S, Steinarsdottir M, Anamthawat-Jonsson K. Eyfjörd JE, et al. Acta Oncol. 1995;34(5):663-7. doi: 10.3109/02841869509094045. Acta Oncol. 1995. PMID: 7546836

9

Male breast cancer in Iceland.

Jonasson JG, Agnarsson BA, Thorlacius S, Eyfjord JE, Tulinius H. Jonasson JG, et al. Among authors: eyfjord je. Int J Cancer. 1996 Feb 8;65(4):446-9. doi: 10.1002/(SICI)1097-0215(19960208)65:4<446::AID-IJC9>3.0.CO;2-X. Int J Cancer. 1996. PMID: 8621225 Free article.

10

Mutations in exons 5-8 of the p53 gene, independent of their type and location, are associated with increased apoptosis and mitosis in invasive breast carcinoma.

van Slooten HJ, van De Vijver MJ, Borresen AL, Eyfjörd JE, Valgardsdóttir R, Scherneck S, Nesland JM, Devilee P, Cornelisse CJ, van Dierendonck JH. van Slooten HJ, et al. Among authors: eyfjord je. J Pathol. 1999 Dec;189(4):504-13. doi: 10.1002/(SICI)1096-9896(199912)189:4<504::AID-PATH483>3.0.CO;2-A. J Pathol. 1999. PMID: 10629550

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

151 results

Search Page